Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 23 February, 2021

Folio Investments

Form 8.1(a) - AON PLC

RNS Number : 0627Q
Folio Investments, Inc.
23 February 2021
 

 

FORM 8.1(a)&(b)(i)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

FOLIO INVESTMENTS, INC.

Company dealt in

AON PLC

Class of relevant security to which the dealings being disclosed relate (Note2)

Ordinary

Date of dealing

22 February 2021

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in  (Note 3)

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

19.16281

(0.00)

0

(0.00)

(2) Derivatives (other than options)

0

(0.00)

0

(0.00)

(3) Options and agreements to purchase/sell

0

(0.00)

0

(0.00)

Total

19.16281

(0.00)

0

(0.00)

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in  (Note 3)

 

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

 

3.  DEALINGS (Note 4)

(a) Purchases and sales

 

Purchase/sale

Number of relevant securities

Price per unit  (Note 5)

Purchase

0.54266

228.722900 USD

Sale

0.44189

228.627200 USD

Sale

0.63497

229.517950 USD

 

(b) Derivatives transactions (other than options transactions)

 

Product name, e.g. CFD

Nature of transaction  (Note 6)

Number of relevant securities  (Note 7)

Price per unit  (Note 5)

 

 

 

 

 

(c) Options transactions in respect of existing relevant securities

 

(i) Writing, selling, purchasing or varying

 

Product name,e.g. call option

Writing, selling,  purchasing, varying etc.

Number of securities to which the option relates  (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit  (Note 5)

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Product name,e.g. call option

Number of securities

Exercise price per unit  (Note 5)

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities)  (Note 4)

 

Nature of transaction  (Note 6)

Details

Price per unit (if applicable)  (Note 4)

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.  If none, this should be stated. 

NONE

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

23 February 2021

Contact name

Paul Grainger and Kashif Rafiq

Telephone number

+44(20) 7552 9835 / +44(20) 7051 0547

Name of offeree/offeror with which associated

WILLIS TOWERS WATSON PLC

Specify category and nature of associate status (Note 10)

Advisor to Offeree

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEPPUQCPUPGGGW

a d v e r t i s e m e n t